166 related articles for article (PubMed ID: 37644546)
21. Economic burden of cardiovascular diseases before and after Iran's health transformation plan: evidence from a referral hospital of Iran.
Alipour V; Zandian H; Yazdi-Feyzabadi V; Avesta L; Moghadam TZ
Cost Eff Resour Alloc; 2021 Jan; 19(1):1. PubMed ID: 33390167
[TBL] [Abstract][Full Text] [Related]
22. The Economic Burden of Acute Myeloid Leukemia in Iran.
Alipour V; Rad S; Nargesi S; Mezginejad F; Jahangiri R; Dolatshahi Z; Mousavi SA; Moshkani Z
Iran J Public Health; 2022 Nov; 51(11):2599-2607. PubMed ID: 36561245
[TBL] [Abstract][Full Text] [Related]
23. The Direct Medical Costs of Breast Cancer in Iran: Analyzing the Patient's Level Data from a Cancer Specific Hospital in Isfahan.
Davari M; Yazdanpanah F; Aslani A; Hosseini M; Nazari AR; Mokarian F
Int J Prev Med; 2013 Jul; 4(7):748-54. PubMed ID: 24049592
[TBL] [Abstract][Full Text] [Related]
24. Economic Burden of Epidermolysis Bullosa Disease in Iran.
Forghani SF; Jahangiri R; Ghasemi F; Shirani R; Bagheri H; Mahmoodi R; Bagheri Faradonbeh S
Med J Islam Repub Iran; 2021; 35():146. PubMed ID: 35321378
[No Abstract] [Full Text] [Related]
25. Economic burden of breast cancer in northern Serbia.
Milovic M; Tamas T; Crnobrnja V; Paut Kusturica M
Front Public Health; 2023; 11():1265301. PubMed ID: 38162600
[TBL] [Abstract][Full Text] [Related]
26. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
27. The economic burden of osteoporosis in Iran in 2020.
Ostovar A; Mousavi A; Sajjadi-Jazi SM; Rajabi M; Larijani B; Fahimfar N; Daroudi R
Osteoporos Int; 2022 Nov; 33(11):2337-2346. PubMed ID: 35821307
[TBL] [Abstract][Full Text] [Related]
28. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.
Cruess AF; Zlateva G; Xu X; Soubrane G; Pauleikhoff D; Lotery A; Mones J; Buggage R; Schaefer C; Knight T; Goss TF
Pharmacoeconomics; 2008; 26(1):57-73. PubMed ID: 18088159
[TBL] [Abstract][Full Text] [Related]
29. Cost of Illness of COVID-19 and Its Consequences on Health and Economic System.
Rajabi M; Rezaee M; Omranikhoo H; Khosravi A; Keshmiri S; Ghaedi H; Pourreza A
Inquiry; 2022; 59():469580221144398. PubMed ID: 36572983
[TBL] [Abstract][Full Text] [Related]
30. Humanistic and Economic Burden of Blindness Associated with Retinal Disorders in a Brazilian Sample: A Cross-Sectional Study.
Lopes N; Dias LLDS; Ávila M; Japiassú RM; Muccioli C; Bordon AF; Arantes TE; Tanaka T; Nassaralla Júnior JJ; Casella AM; Nehemy MB; Ferreira M; Mauad RF
Adv Ther; 2021 Aug; 38(8):4215-4230. PubMed ID: 33791953
[TBL] [Abstract][Full Text] [Related]
31. Estimating the Cost of Illness of Prostate Cancer in Iran.
Mojahedian MM; Toroski M; Keshavarz K; Aghili M; Zeyghami S; Nikfar S
Clin Ther; 2019 Jan; 41(1):50-58. PubMed ID: 30545740
[TBL] [Abstract][Full Text] [Related]
32. Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China.
Lu J; Xu A; Wang J; Zhang L; Song L; Li R; Zhang S; Zhuang G; Lu M
BMC Health Serv Res; 2013 Jan; 13():37. PubMed ID: 23368750
[TBL] [Abstract][Full Text] [Related]
33. Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study.
Chuvarayan Y; Finger RP; Köberlein-Neu J
Eur J Health Econ; 2020 Feb; 21(1):115-127. PubMed ID: 31493181
[TBL] [Abstract][Full Text] [Related]
34. Economic burden for retinoblastoma patients in China.
Zhou Y; Cai S; Jin M; Jiang C; Xu N; Duan C; Peng X; Zhao J; Ma X
J Med Econ; 2020 Dec; 23(12):1553-1557. PubMed ID: 33000977
[TBL] [Abstract][Full Text] [Related]
35. Economic Burden of Gynecological Cancers in Iran.
Sargazi N; Daroudi R; Zendehdel K; Hashemi FA; Tahmasebi M; Darrudi A; Nahvijou A
Value Health Reg Issues; 2022 Mar; 28():1-6. PubMed ID: 34794064
[TBL] [Abstract][Full Text] [Related]
36. Direct and indirect cost of managing Alzheimer's disease in the Islamic Republic of Iran.
Aajami Z; Kebriaeezadeh A; Nikfar S
Iran J Neurol; 2019 Jan; 18(1):7-12. PubMed ID: 31316730
[No Abstract] [Full Text] [Related]
37. Economic burden of colorectal cancer in Iran in 2012.
Vahdatimanesh Z; Zendehdel K; Kbari Sari AA; Farhan F; Nahvijou A; Delavari A; Daroudi R
Med J Islam Repub Iran; 2017; 31():115. PubMed ID: 29951416
[No Abstract] [Full Text] [Related]
38. Evaluating Direct Costs of Gastric Cancer Treatment in Iran - Case Study in Kerman City in 2015.
Izadi A; Sirizi MJ; Esmaeelpour S; Barouni M
Asian Pac J Cancer Prev; 2016; 17(6):3007-13. PubMed ID: 27356726
[TBL] [Abstract][Full Text] [Related]
39. The economic burden of low back pain in KwaZulu-Natal, South Africa: A prevalence-based cost-of-illness analysis from the healthcare provider's perspective.
Kahere M; Ngcamphalala C; Östensson E; Ginindza T
PLoS One; 2022; 17(10):e0263204. PubMed ID: 36227919
[TBL] [Abstract][Full Text] [Related]
40. The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review.
Witkowski M; Moreno SI; Fernandes J; Johansen P; Augusto M; Nair S
Pharmacoeconomics; 2022 Aug; 40(8):751-776. PubMed ID: 35789987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
